FDA Approved: VINORELBINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Vinorelbine from Actavis Pharma, Inc., indicating an update to its labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)

Snippet

SUPPL AP for VINORELBINE (VINORELBINE)